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Background. Alcohol dependence and associated cognitive impairments apparently result from neuroadaptations to chronic
alcohol consumption involving changes in expression of multiple genes. Here we investigated whether transcription factors of
Nuclear Factor-kappaB (NF-kB) family, controlling neuronal plasticity and neurodegeneration, are involved in these
adaptations in human chronic alcoholics. Methods and Findings. Analysis of DNA-binding of NF-kB (p65/p50 heterodimer)
and the p50 homodimer as well as NF-kB proteins and mRNAs was performed in postmortem human brain samples from 15
chronic alcoholics and 15 control subjects. The prefrontal cortex involved in alcohol dependence and cognition was analyzed
and the motor cortex was studied for comparison. The p50 homodimer was identified as dominant kB binding factor in
analyzed tissues. NF-kB and p50 homodimer DNA-binding was downregulated, levels of p65 (RELA) mRNA were attenuated,
and the stoichiometry of p65/p50 proteins and respective mRNAs was altered in the prefrontal cortex of alcoholics.
Comparison of a number of p50 homodimer/NF-kB target DNA sites, kB elements in 479 genes, down- or upregulated in
alcoholics demonstrated that genes with kB elements were generally upregulated in alcoholics. No significant differences
between alcoholics and controls were observed in the motor cortex. Conclusions. We suggest that cycles of alcohol
intoxication/withdrawal, which may initially activate NF-kB, when repeated over years downregulate RELA expression and NF-
kB and p50 homodimer DNA-binding. Downregulation of the dominant p50 homodimer, a potent inhibitor of gene
transcription apparently resulted in derepression of kB regulated genes. Alterations in expression of p50 homodimer/NF-kB
regulated genes may contribute to neuroplastic adaptation underlying alcoholism.
Citation: O ¨kvist A, Johansson S, Kuzmin A, Bazov I, Merino-Martinez R, et al (2007) Neuroadaptations in Human Chronic Alcoholics: Dysregulation of
the NF-kB System. PLoS ONE 2(9): e930. doi:10.1371/journal.pone.0000930
INTRODUCTION
Although mechanisms of alcoholism remain to be elucidated, the
molecular hypothesis postulates that that alcohol dependence and
toxicity result from neuroadaptations to chronic alcohol consump-
tion based on alterations in gene expression. Molecular and
cellular adaptations in the nucleus accumbens, ventral tegmental
area, amygdala and prefrontal cortex (PFC) [1,2] have been
implicated in the behavioral changes such as craving and relapse
induced by chronic alcohol consumption. Chronic alcohol abuse
also causes deficits in perceptual-motor skills, visual-spatial
functions, abstraction and problem solving [3,4]. These impair-
ments may be related to alcohol-induced damage to the PFC and
hippocampus [5,6]. White matter and cell loss in the PFC, loss of
hippocampal volume and shrinkage of hippocampal neurons are
characteristic of these maladaptations [7–11].
Earlier work has found that alcohol abuse is associated with
widespread changes in gene expression in the PFC of human brain
[12–14]. Differentially expressed genes form functional groups
implicated in immune response, cell survival, inflammation, signal
transduction and energy production. Pronounced differences have
been found in genes involved in myelination, protein trafficking,
apoptosis and neurogenesis [12–14]. Re-programming of gene
expression in chronic alcoholics apparently involves transcription
factors that are responsive to the primary effects of ethanol, and
that regulate multiple pathways leading to neuropathology and
neuronal dysfunctions.
Transcription factors of the NF-kB family are inducible proteins
that regulate expression of genes involved in inflammation,
immune response and cell survival [15–17]. These factors are
homo- or heterodimers of p65 (Rel A), p50 and other proteins of
the NF-kB family. The p65/p50 heterodimer (NF-kB) generally
activates gene transcription while the p50 homodimer represses it
[18,19]. In most cell types, NF-kB is sequestered in the cytoplasm
in a complex with inhibitor IkB proteins. Nuclear translocation of
NF-kB is induced by multiple extracellular stimuli that trigger
activation of an IkB kinase (IKK) complex, which phosphorylates
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degradation. The released NF-kB migrates to the nucleus to act
as a transcription factor. The IKK complex contains the two
kinases IKKa and IKKb and the regulatory subunit NEMO/
IKKc, and functions as integrator of signals regulating NF-kB
activity. Transactivating capacity is also regulated in the cell nuclei
through phosphorylation of p65 and p50 by IKKb and other
kinases [20–22]. In the brain, the p65 and p50 NF-kB subunits are
abundantly expressed in neurons and glia, and a substantial
fraction of NF-kB is located in the cell nuclei and constitutively
active [15,16,23,24]. The NF-kB-mediated activation of gene
transcription contributes to long-term changes in synaptic
signaling, cognitive behavior, developmental cell death and
chronic neurodegenerative disorders [15,16,25–31].
Several observations including NF-kB activation by glutamate,
cytokines and oxidative stress, ability to transmit signals from the
cytoplasm and synapses to the cell nuclei and regulation of synaptic
plasticity and neuron survival [15,16,22,25–29], suggest a role of this
transcription factor in adaptation to chronic alcohol intake.
Induction of oxidative stress by alcohol and alcoholism-associated
alterations in the expression of inflammatory, cell survival and
myelin genes [12–14] regulated by NF-kB [15–17,32,33] support
this hypothesis. In the present study, we aimed to evaluate whether
the NF-kBsystemisinvolved inneuroadaptationofthehuman brain
to chronic alcohol abuse. The PFC involved in alcohol dependence
and cognitive behavior, and impaired in human chronic alcoholics
was chosen for analysis. The motor cortex (MC) that is not engaged
in these processes to the same extent and is less affected by alcohol
with respect to neuronal density [8,10], was studied for comparison.
The NF-kB system was characterized with biochemical and
molecular techniques, and the alterations found were correlated
with changes in the pattern of gene expression previously identified
in the PFC of human chronic alcoholics [14].
MATERIALS AND METHODS
Case Selection
Brain samples (superior frontal cortex,Brodmann area 9 and motor
cortex, Brodmann area 4) were obtained from the Tissue Resource
Center, University of Sydney, Australia (http://www.braindonors.
org). A total of 30 cases, all males, including 15 alcoholic and 15
control subjects were analyzed (Table 1). Alcoholic and control
cases were matched for age at death, and postmortem interval
(PMI). Alcohol subjects met criteria for Diagnostic and Statistical
Manual for Mental Disorders, 4th edition, (American Psychiatric
Association) [34] and also National Health and Medical Research
Council (NHMRC)/World Health Organization criteria as
individuals who consumed greater than 80 g of ethanol per day
for the majority of their adult lives. Controls had either abstained
from alcohol completely or were social drinkers who consumed less
than 20 g of ethanol per day on average. Cases with a history of
poly drug abuse (evidence that the individual abused other drugs
such as cocaine or heroin) or with medical complications such as
liver cirrhosis and the Wernicke–Korsakoff syndrome or alcoholic
cases with concomitant diseases were excluded. Samples were
taken by qualified pathologists under full ethical clearance from the
Sydney South West Area Health Service Human Ethics Commit-
tee (X03-0117) and informed written consent from the next of kin,
kept at 280uC and shipped to Sweden on dry ice.
mRNA quantification by TaqManH low density array
RNA preparation was performed using RNeasy Lipid Tissue Mini
Kit (QIAGEN, Maryland, USA). RNA was quantified by
NanodropH and Agilent 2100 Bioanalyzer (Agilent, Palo Alto,
CA) was used to control RNA quality. Only RNA with clear
ribosomal RNA, 18S and 28S, was used for further analysis. cDNA
was synthesized with the High Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA). mRNA levels were
quantified by TaqManH Low Density Arrays (Applied Biosystems,
Foster City, CA). In a pre-prepared micro fluidic card containing
probes and primers for each gene, cDNA and TaqManH Universal
PCR Master Mix (Applied Biosystems) was added in a final
concentration of 65 pg cDNA per sample and gene. Every sample
was run in duplicate on the same array for each gene. The PCR
amplification was performed at 50uC for 2 min, 94. 5uC for 10 min
and 40 cycles of 97uC for 30 seconds followed by 59.7uC for 1 min.
To measure the quantity of a given RNA species, the threshold
cycles (Ct) were monitored by the Applied Biosystems 7900HTFast
Real-Time PCR System. Each mRNA expression was calculated
by relative quantification using a normalization factor (geometric
mean of two reference genes selected by geNORM program,
http://medgen.ugent.be/genorm/) [35] and qBASE program for
internal and external calibration and also for easy care of large RT-
PCR datasets (http://medgen.ugent.be/qbase/). According to our
analysis of reference genes [36] the beta-actin (ACTB) and
ribosomal large P0 (RPLP0) genes for PFC, and the 18S and
RPLP0 genes for the MC were chosen for normalization.
Western Blot Analysis
Powdered tissue samples were boiled in pre-warmed SDS extrac-
tion buffer (0.45 M Tris-HCl, pH 8.5, 2.5% glycerol, 4% SDS,
0.5 mM DTT and 56protease inhibitors for 5 min, sonicated and
protein extracts were aliquoted and kept at 280uC until usage.
Protein concentration was determined with the DC protein assay
(Bio-Rad Laboratories, Hercules, CA, USA). Aliquots of tissue
extracts (50–120 mg protein) were heated for 5 min at 95uC in the
presence of 5 mM b-mercaptoethanol and resolved by SDS-
PAGE on 10% Tricine gels as described earlier [37]. Reference
samples consisting of pooled cerebellar extracts from control
subjects were loaded onto three wells, on each edge and in the
middle of each gel and their density values were used to ascertain
reproducibility on each blot and interblot comparison. Proteins
were transferred onto nitrocellulose membranes (Schleicher and
Schuell, Dassel, Germany) at 4uC and stained with Memcode
Reversible Protein Stain Kit (Pierce, Rockford, USA). Densitom-
etry values of protein load were used for normalization of Western
blot data. After destaining, membranes were incubated with
stripping buffer (62.5 mM Tris-HCl, 2% SDS, 100 mM b-
mercaptoethanol, pH 6.7) for 20 min at 55uC, blocked for
30 min with 5% non-fat dry milk in 50 mM Tris-HCl, 0.15 M
NaCl, 0.05% Tween 20 buffer and probed with rabbit polyclonal
antibodies against the human NF-kB p50 or p65 subunits (PC136,
1:2000; PC137, 1:2000; Calbiochem, San Diego, CA, USA), or
goat polyclonal antibodies against the C-terminus of human IKKb
(sc-7329; 1:500; Santa Cruz, California, USA). Goat anti-rabbit
(Bio Rad) or rabbit anti-goat (Sigma) antibodies all conjugated
with horseradish peroxidase (HRP) were used as secondary
antibodies. Membranes were developed with the ECL detection
system (Amersham, Little Chalfont, UK). Fuji Film Image Gauge
software was used for densitometric analysis.
NF-kB DNA binding activity
Preparation of whole tissue extracts All experimental pro-
cedures were carried out at +4uC. Tissue extracts were prepared
by a modification [24] of the protocol described elsewhere [38,39];
powdered tissue preparations (25–35 mg) were homogenized in 4
volumes of Buffer C (20 mM HEPES, pH 7.9, 0.42 M NaCl, 25%
NF-kB system in alcoholics
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NP-40, 25 mM proteasome inhibitor MG132 and 56protease
inhibitors (Complete, Roche, Switzerland)) by 10 strokes with
plastic pestles (Sigma-Aldrich, St. Louis, MO, USA) in Eppendorf
tubes, incubated for 10 min, homogenized again by 10 strokes and
centrifuged at 20,0006g for 15 min at 4uC. The supernatant was
kept at 280uC until assayed. Protein concentration was
determined using the DC protein assay.
Oligonucleotides The following oligonucleotides were SDS-
PAGE purified and [P
32] labeled with Klenow enzyme as
described earlier [24]. Sequence of the plus strand of wild type
(wt) and mutant (m)-kB fragments of the immunodeficiency virus
enhancer [40] is shown; wt- and m-kB-sites are underlined and
mutated nucleotides are indicated by bold letters: wt-kB5 9-
GGTGATCAGGGACTTTCCGCTGGGGACTTTCCAGGAT-
39,m - kB5 9-GGTGATCATTCACTTTCCGCTATTCACTTT-
CCAGGAT-39. Minusstrands wereextended 1 to 3 nucleotidesfrom
the 59-end and recessed by 1-3 nucleotides from the 39-end.
Electrophoretic mobility shift assay (EMSA) The EMSA
was performed essentially as described previously [24]. Protein
extracts (10 mg) were added to the binding mixture (20 mlo f
10 mM Tris-HCl, pH 7.5, 20 mM KCl, 1 mM EDTA, 7.5%
Table 1. Demographic data of alcoholics and control subjects
..................................................................................................................................................
Subject No. Age, years PMI, hs Brain pH Cause of death
Toxicologic findings at time
of death Smoking history
Controls
1 34 20.5 6.73 Acute exacerbation of asthma NA Smoker
2 78 6.5 6.2 Dehydration and adenocarcinoma of
the lung and rectum with multiple
metastases
None Non smoker
3 63 72 6.9 Coronary-artery atherosclerosis None Smoker
4 82 23.5 6.4 Sepsis None NA
5 38 13.5 6.26 ACSVD None Smoker
6 69 16 6.6 ACSVD Paracetamol, carbon monoxide Smoker
7 56 24 6.53 Coronary-artery atheroma NA Smoker
8 59 20 6.56 Coronary thrombosis None Smoker
9 56 25 6.1 CAD Codeine, morphine, naproxen NA
10 56 37 6.76 LV scarring, hypertension and
cardiomegaly
None Smoker
11 82 36 6.24 Myocardial infarction NA Non smoker
12 44 50 6.6 CAD None Smoker
13 51 20 5.88 Cardiac tamponade None NA
14 61 24 6.52 CAD NA Smoker
15 53 16 6.84 Dilated cardiomyopathy Lignocaine, sotalol Non smoker
Mean6S.E.M. 59612 7 61 6.4760.02
Alcoholics
1 34 8.5 6.61 Hanging Alcohol Smoker
2 77 20 6.34 Lobular pneumonia None Smoker
3 65 32 5.66 Seizures and cardiac arrest Codeine, moclobemide,
paracetamol, phenytoin, quinine
NA
4 79 48 6.34 CAD Temazepam Smoker
5 39 24 6.56 Aortic sclerosis NA Smoker
6 70 33.5 6.24 Respiratory failure None Smoker
7 56 45 6.51 BEV Alcohol NA
8 59 24 6.57 Cardiomyopathy None Non smoker
9 56 22 6.52 CAD and UGIH None Smoker
10 56 15 6.66 CAD and emphysema Nordiazepam NA
11 81 36 6.44 Sepsis None Smoker
12 44 15 6.48 CAD Diazepam, noridazepam Non smoker
13 52 45.5 6.78 Lobar pneumonia None Smoker
14 62 49 6.49 CAD Sertraline Smoker
15 53 57 6.75 CAL NA Smoker
Mean6S.E.M. 59613 2 61 6.4660.02
Abbreviations: ACSVD, atherosclerotic cardiovascular disease; BEV, bleeding esophageal varices; CAD, ischaemic heart disease; CAL, chronic airflow limitation; LV, left
ventricular; NA, not available; PMI, postmortem interval and UGIH, upper gastrointestinal hemorrhage. Smoker group includes smokers, ex-smokers (subjects ## 3, 12
and 14 in controls, and 11 and 14 in alcoholics) and occasional smoker (subject #1 in controls).
doi:10.1371/journal.pone.0000930.t001
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32P] –
labeled oligonucleotide) in duplicates and incubated for 20–
30 minutes at room temperature. The reaction mixture was
brought to 0.6% or 0.03% deoxycholate (DOC) after 30 min
followed by the addition of 1.2% NP-40 and were loaded onto
a 5% polyacrylamide gel in 0.56TGE (25 mM Tris-HCl, 0.19 M
glycine, 1 mM EDTA, pH 8.5) buffer. Reference samples
consisting of pooled cerebellar extracts from control subjects
were loaded onto two wells on each edge of the gel to ascertain
reproducibility of the gel, and also for inter-gel comparison. In
competition experiments, 10 ng of unlabeled wt-kBo rm - kB
oligonucleotide was added to the incubation mixture prior to
the initiation of the binding reaction. After electrophoresis the
gels were fixed in 40% methanol containing 3% acetic acid for
10 min, dried and exposed to intensifying screen. Detection was
performed on phosphorimager BAS 1500 (Fuji Film, Kanagawa,
Japan) and densities were analyzed using Fuji Film Image Gauge
software.
Computational Analysis
NF-kB- and p50 homodimer DNA-binding sites in genes
differentially expressed in the PFC of human alcoholics compared
to control subjects [14] were analyzed with the Prometheus system
[41]. Transcription Factor (TF) Binding Sites (TFBS) were
identified in phylogenetically conserved (human versus rat) regions
of the 10 kb-promoter region. The weight matrices for TFBS
identification were taken from JASPAR [42]. Prometheus uses the
GeneLynx Database [43] and the GeneLynx application pro-
gramming interface to obtain the genomic coordinates and
sequences for human and rat species with an upstream promoter
length of 10 kb. LAGAN aligner algorithm was run using a max
gap length of 5 bp, a conservation rate of 45 bp, conservation
super rate of 65 bp and a score cutoff of 25 bp [44,45]. The TFBS
finding algorithms were run using a window size of 50 bp,
a conservation cutoff of 70% and a TF score threshold of 80% for
human-rat comparison. The system uses the Grid computing
paradigm [46] for the execution of computationally intensive steps
involved in the TFBS finding process: genomic sequence align-
ment and TFBS searching. The Grid computational resources are
provided by NorduGrid Virtual Organization (http://www.
nordugrid.org/). Significance of differences in a number of TFBS
between gene sets was evaluated with the Chi-Square test. 479 out
of 531 differentially expressed genes identified by Liu et al. [14]
were analyzed (Table supplemental (S) 1); 52 out of the 531 genes
were not included because of missing annotations/sequences.
Brain autopsy material used in the present and Liu et al. [14]
studies was partially obtained from the same source (Tissue
Resource Center, University of Sydney); only two of all subjects
were analyzed in both studies. Sets of downregulated and
upregulated genes were compared with each other, and with
a control set of 1164 genes (Table S1). Control set did not include
genes differentially expressed in the PFC of alcoholics.
Statistical Analysis
Results are expressed as mean and standard deviation (normally
distributed variables) or median and range (non-normal distribu-
tion). Normality of data distribution was analyzed using Shapiro-
Wilk’s W-test. In data sets that were not normally distributed non-
parametric analysis (Mann-Whitney and Spearman correlations)
was used. A general stepwise linear regression model was used to
evaluate group differences and identify covariates (age, brain pH
and postmortem interval). Student’s t-test was used to assess
differences between groups when no covariates were found.
Variables with a significant association with group were included
in the final statistical model as covariates. Pearsons correlation
analysis was performed to determine the association between
different variables. Slopes in the correlation equation were
compared with a multiple regression model. Differences in the
number of up-, down-regulated and control genes containing
TFBS were evaluated with Chi-Square test. Significance was set at
P,0.05 and trends considered for P,0.10. Statistical analysis was
carried out using the Statistica 6.0 package (StatSoft Scandinavia,
Uppsala, Sweden).
RESULTS
The demographic characteristics of control and alcoholic subjects
are given in Table 1. We found no significant differences in
age (t28=0.01, P=0.99), PMI (t28=0.85, P=0.40) and propor-
tions of smokers and nonsmokers (Fisher test, P=0.5) between
controls and alcoholics. All subjects were Caucasian male. Brain
pH was determined to assess the agonal state. The mean brain pH
of controls and alcoholics were 6.4660.29 and 6.4760.27,
respectively, which was not significantly different (t28=0.11,
P=0.91).
mRNA expression levels of NF-kB related genes
RELA, NFKB1, NFKB2, RELB, IKKb and IkBa mRNAs that give
rise to p65, p50, p52, Rel B, IKKb and IkBa proteins were
quantified in the PFC (Brodmann area 9) of human chronic
alcoholics and control subjects (n=15/group), and in the MC
(Brodmann area 4) of the same subjects using TaqManH Low
Density Arrays (Table 2; n=15/group). In the PFC, RELA mRNA
was significantly decreased by 1.41 fold in alcoholics compared to
the control group (stepwise linear regression F2,27=10.03,
P=0.003, covariate pH). No group6pH interaction was observed.
The levels of the other five mRNAs did not differ significantly
between alcoholics and controls. In the MC, a trend for an
increase in the RELB mRNA levels in alcoholics (Student’s t-test,
T1,28=1,89, P=0.069) was observed whereas the levels of other
five mRNAs showed no significant differences between the groups
(Table S2).
p65, p50 and IKKb protein levels
Levels of p65 and p50 NF-kB subunits and IKKb protein were
examined by western blotting. Each protein analyzed was
identified as a single band with the predicted molecular size–65
(p65), 50 (p50) and 87 (IKKb) kDa (Figure 1). The optical density
values obtained for the proteins were within the linear range of
detection as was evident from experiment with serial dilutions of
reference samples; densitometry assessment of bands showed
linear dependence with correlation coefficient equal to 0.998
between protein immunoreactivity measured as optical density
and protein load measured as Memcode optical density (see also
[37]). For inter-gel comparison, the optical density of proteins in
each sample was expressed as a percentage of reference samples on
a given gel, and these values were used for statistical analysis.
Similar to the levels of RELA mRNA, the p65 levels in the PFC of
alcoholics were decreased by 1.46-fold (Table 2) but the
differences did not reach statistical significance. The levels of
p65 in the MC, and those of p50 and IKKb proteins in neither the
PFC (Table 2; n=15) nor MC (Table S2; n=15) differed
significantly between control subjects and alcoholics. We were
unable to analyze other NF-kB related proteins including cREL,
IkBa, IKKa and IKKc in postmortem human brain samples due
to the absence of specific and sensitive antibodies suitable for such
study or low levels of expression.
NF-kB system in alcoholics
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To test whether stoichiometry between components of the NF-kB
system was altered in alcoholics we analyzed the ratio of levels of
p65/p50, IKKb/p65 and IKKb/p50 proteins and respective
mRNAs. The p65/p50 protein ratio was significantly decreased
(1.23-fold; Mann Whitney U-test, Z1,28=2.38, P=0.017) while
the IKKb/p65 protein ratio increased (1.44-fold; stepwise linear
regression, F2,27=5.78, P=0.023, covariate age) in the PFC of
alcoholics (Figure 2A; n=15). There was a significant age6group
interaction with a negative correlation to age in both groups.
The RELA/NFKB1 and IKKb/RELA mRNA ratio was signifi-
cantly decreased (1.37-fold) or increased (1.62-fold), respectively,
in alcoholics compared to control subjects (Figure 2B; n=15/
group; Student’s t-test, T1,28=2,18, P=0.038 and T1,28=2,21,
P=0.035). These differences were not due to lower levels of RELA
mRNA (1.41-fold) in alcoholics because the levels of NFKB1 and
IKKb mRNAs were also decreased by 1.22 and 1.23-fold,
respectively, in this group. No significant differences in these
protein and mRNA ratios were observed in the MC. Changes in
mRNA stoichiometry may result in the disproportion in p65 and
p50 protein content affecting formation of NF-kB complexes, and
altered IKKb-mediated p65 phosphorylation.
NF-kB DNA binding activity
NF-kB DNA-binding activity was compared in alcoholics and
controls using EMSA. The assay identified three main complexes
in both PFC and MC (Figure 3A). Two upper complexes (I, II)
were specific since their formation was inhibited in the presence of
unlabeled wt-kB oligonucleotide (Figure 3A, lane 2) but not m-kB
oligonucleotide (Figure 3A, lane 3). Formation of the third, lower
complex (III) was not blocked by wt- or m-kB oligonucleotide
demonstrating low specificity and affinity of this factor for binding
to DNA. We previously identified protein factors in the complexes
I and II as NF-kB (p50/p65 heterodimer) and p50 homodimer,
respectively, using the supershift/depletion assay with anti-p65-
and p50-antibodies and also UV-crosslinking in extracts of human
neuronal cell lines and rat brain [24,47]. We also identified
complex III as the Ku protein that binds to double-stranded DNA
ends, does not recognize specific DNA sequences, and is present at
high levels in the human brain [48,49]. The levels of the
constitutively active and total (active plus latent) NF-kB DNA-
binding were measured in the presence of 0.03% and 0.6% DOC,
respectively; at high concentration DOC dissociates complexes of
NF-kB with the IkB inhibitory protein [24,38,47]. The NF-kB/
complex I was induced by pre-incubation of extracts from the PFC
of control subjects or alcoholics with 0.6% DOC only by 12% and
14%, respectively; thus NF-kB was virtually present in the
activated form in this structure (Figure 3A, lane 4). 0.6% DOC
slightly inhibited p50 homodimer binding to DNA. The p50
homodimer was a dominant kB binding factor in the human
cortex; the levels of its DNA-binding activity exceeded those of
NF-kB by 2.4–2.7 fold in the PFC and MC of controls and
alcoholics (Student’s t-test for dependent samples: PFC/controls,
T1,10=8.56, P,0.0001, n=11; PFC/alcoholics, T1,12=12.77,
P,0.0001, n=13 (see Figure 3B, lines 1, 2, 4–8); MC/controls,
T1,10=10.83, P,0.0001, n=11; MC/alcoholics, T1,12=8.48,
P,0.0001, n=13).
DNA-binding complexes were identified in the PFC and MC in
24 out of 30 subjects analyzed. In contrast, the NF-kB, p50
homodimer and Ku DNA-binding activity was much lover or
virtually undetectable in extracts from other 4 control and 2
alcoholic subjects (Figure 3B, lanes 3 and 15). Stepwise linear
regression identified pH (p,0.05) as a covariate for the DNA
binding activities in the PFC and MC when 30 subjects were
analyzed. The six subjects, which extracts failed to produce
complexes, had the lowest brain tissue pH ranging from 5.66 to
6.24; the average brain pH for the remaining subjects was
6.6160.19 and 6.5460.14 for the control and alcoholic groups,
respectively. Thus, DNA binding proteins including NF-kB, p50
homodimer and Ku were probably inactivated due to the low pH
level of the sample. When these six subjects were excluded from
the analysis, the remaining samples showed no correlation
between pH and DNA binding activity.
The p50 homodimer DNA binding activity (Table 2; Student’s
t-test with unequal variances; T1,14.9=2.41, P=0.029), and the
constitutively active and total NF-kB DNA-binding activity
(Student’s t-test with unequal variances; active, T1,14.3=2.31,
Table 2. Levels of the NF-kB and p50 DNA-binding, proteins
and mRNAs in the PFC of alcoholics and control subjects
......................................................................
Control group Alcohol group P-value
Mean6SD Mean6SD
mRNA levels
RELA 2.5960.97 1.8460.74 0.003
b
NFKB1 2.1860.87 1.7960.58 0.15
a
IKKb 2.0960.81 1.7060.53 0.14
a
IkBa 2.4861.24 1.8761.04 0.11
c
NFKB2 2.6461.31 2.4161.27 0.95
c
RELB 2.1961.03 2.4861.69 0.81
a
Protein levels
p65 0.8160.36 0.6860.40 0.206
c
p50 0.8160.33 0.9560.37 0.269
a
IKKb 0.6860.17 0.6860.26 0.947
a
DNA binding activity
NF-kB (Act) 67.3627.2 46.4613.9 0.037
a
NF-kB (Tot) 63.3618.7 42.3622.5 0.010
c
(p50)2 72.1622.9 53.5612.5 0.029
a
mRNA levels are presented as normalized relative expression levels. Protein
levels are presented as relative values calculated from the optical density of
p65, p50 or IKKb bands as a percent from internal control samples and
normalized to Memcode staining. Protein and mRNA levels were analyzed in 15
control subjects and 15 alcoholics. NF-kB (Act), constitutively active NF-kB;
NF-kB (Tot), total NF- kB activated by 0.6% DOC. Values for DNA binding activity
are presented as percent of those obtained with the internal control samples
loaded on each gel (control group: n=11; alcoholic group: n=13). Significance
of differences between groups was evaluated by
a Student’s t-test,
b covariance
by multiple regression analysis (RELA, covariate pH), or
c Mann Whitney U-test
dependent on the normality of data distribution.
doi:10.1371/journal.pone.0000930.t002
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Figure 1. WB images of p65, p50 and IKKb proteins in the PFC.
Representative blots of three control subjects (c) and three alcoholics (a).
doi:10.1371/journal.pone.0000930.g001
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PLoS ONE | www.plosone.org 5 September 2007 | Issue 9 | e930Figure 2. Stoichiometry of p65/p50 and IKKb/p65 proteins (A), and RELA/NFKB1 and IKKb/RELA mRNAs (B). Results are presented for the PFC of
alcoholics (n=15) and control subjects (n=15) as mean6SD. Significance of differences between groups was evaluated by Mann Whitney U-test (A,
p65/p50), covariance by multiple regression analysis (A, IKKb/p65, covariate age; age6group interaction), or Student’s t-test (B). * P,0.05.
doi:10.1371/journal.pone.0000930.g002
Figure 3. kB–binding factors in the PFC identified by EMSA. (A) The constitutively active kB-DNA binding activity was determined by incubation of
tissue extracts with labeled kB-oligonucleotide followed by treatment with 0.03% DOC solution (DOC-) that did not affect DNA-protein complex
formation and was used as a control. Latent factors were activated for binding to DNA by treatment with 0.6% DOC (DOC+) that dissociated IkB
inhibitory protein from complexes with NF-kB, thus allowing to measure the total DNA-binding. Total NF-kB activity consisted of the constitutively
active and DOC-activated DNA binding activities. The specificity of DNA-protein complexes was assessed by competition with wild type-kB (wt) or
mutant-kB (m) oligonucleotides. Upper sequence-specific complexes I and II consisted of NF-kB and p50 homodimer, respectively, as demonstrated
previously [24,47]. The lower complex III showed no DNA-binding sequence specificity and was probably formed by Ku protein [48,49]. For the upper
image, film was exposured with a gel for longer time than for the lower one. (B) Representative picture of the constitutively active (DOC-) and total
(DOC+) kB–binding activities in the PFC of control subjects and alcoholics. Lanes 3 (subject 13C) and 15 (subject 3A), only weak or no complexes were
formed (see Table 1 for the description of subjects).
doi:10.1371/journal.pone.0000930.g003
NF-kB system in alcoholics
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respectively), were lower in the PFC of alcoholics compared
to controls. No significant differences between alcoholics and
controls in the DNA binding activity of p50 homodimer and
constitutively active NF-kB were found in the MC although a trend
(Student’s t-test; T1;22=2.02, P=0.055) for decrease of the
total NF-kB DNA binding activity was observed in alcoholics
(Table S2).
Correlations
P and r-values of numerically significant correlations are shown in
the Table S3. DNA-binding activity of constitutively active NF-kB
positively correlated with IKKb protein content in the PFC of
both alcoholics and control subjects (Figure 4A). The p65 and p50
protein levels positively correlated in the PFC of the control group
while the correlation was weaker in alcoholics (Figure 4B).
Correlations between the six mRNAs analyzed were evaluated
in each cortex and for alcoholics and control subjects, respectively
(Table S3). Four correlations in the PFC of both alcoholics and
control subjects had r-values that exceeded 0.8 and P,0.0001;
RELA vs. NFKB1 (Figure 4C), RELA vs. IKKb, NFKB1 vs. IKKb and
RELA vs. IkBa (Table S3). The interrelationship of the six NF-kB
mRNA levels and levels of transcripts of the tumor necrosis factor
receptor 1A, p53, myelin basic protein and DNA fragmentation
factor a genes in the PFC were evaluated for comparison; no or
poor correlations were found with most of them having r-values
ranging from 0.1 to 0.6.
NF-kB- and p50 homodimer-binding sites in genes
differentially expressed in alcoholics
Downregulation of DNA-binding of the p50 homodimer and
NF-kB in alcoholics may result in changes in expression of genes
that are regulated through kB elements, binding sites for these
transcription factors. To test this hypothesis we used a computa-
tional approach to compare the number of genes containing kB
elements in two sets of genes that were previously identified by one
of the co-author groups [14] as downregulated (n=270) or
upregulated (n=209) in the PFC of alcoholics (Table S1). A group
of 1164 genes that were randomly selected from the set, which did
not include genes differentially expressed in alcoholics, was studied
for comparison (control genes; Table S1). Previous analyses
human chromosome 22 with chromatin immunoprecipitation
and genomic microarrays [50] demonstrated that kB elements are
enriched at the 59-end of genes. Therefore, we focus on the
identification of kB elements in 10 kb-promoter regions. p50
homodimer and NF-kB bind to virtually the same kB elements.
Weight matrix for NF-kB in the JASPAR database [42] consists of
sequences of the ‘‘NF-kB’’-subtype that are also targets for the p50
homodimer (Figure 5A). p50 protein binds to kB sites as
homodimer and therefore has slightly higher affinity for symmetric
kB elements [51,52]; this is reflected in the composition of the
second kB matrix of the ‘‘p50 homodimer’’-subtype present in the
JASPAR database (Figure 5B). We used both matrices in the
analysis (Figure 5). To increase prediction specificity we used
a phylogenetic footprinting approach based on the observation
that functional Transcription Factor Binding Sites (TFBS) are
more often located in evolutionary conserved regions [53,54].
Analysis of the 479 differentially expressed genes with phylogenetic
footprinting of human-rat gene sequences demonstrated that 58
genes contain one or more putative kB binding sites for both p50
homodimer and NF-kB (the ‘‘NF-kB’’-subtype), and 19 genes
contain at least one putative ‘‘p50 homodimer’’-subtype kB
binding site (Table S4). Among 1164 control genes, 188 genes
contain putative ‘‘NF-kB’’-subtype whereas 77 genes putative
‘‘p50 homodimer’’-subtype of kB binding sites.
Next, we evaluated differences in the proportion of genes that
contain the ‘‘NF-kB’’- or ‘‘p50 homodimer’’-subtypes of kB
elements in 10 kb promoter region between upregulated, down-
regulated and control genes (Figure 5C, D; Table S4). There was
a significant difference in the frequency of occurrence of genes
with each ‘‘NF-kB’’- or ‘‘p50 homodimer’’- subtype of kB
elements between up- and down regulated genes and control
Figure 4. Correlations between DNA-binding activity, protein and
mRNA levels. (A) Constitutively active NF-kB DNA binding correlates
with IKKb protein levels in the PFC of alcoholics (n=13; P=0.002) and
control subjects (n=11; P=0.007). No significant difference was found
between slopes in the alcohol and control group. (B) p65 and p50
protein levels (15 control subjects: P=0.01; 15 alcoholics: P=0.06) and
(C) RELA and NFKB1 mRNA levels (15 control subjects: P,0.0001; 15
alcoholics: P,0.0002) correlate in the PFC.
doi:10.1371/journal.pone.0000930.g004
NF-kB system in alcoholics
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2=8.30, P,0.05; x
2=7.75,
P,0.05). The frequency of each subtype of binding sites in the
downregulated genes was lower compared to the upregulated
genes (Chi-square test, df=1: x
2=4.72, P,0.05; x
2=4.94,
P,0.05) and control genes (Chi-square test, df=1: x
2=8.23,
P,0.01; x
2=7.75, P,0.01) (Figure 5 C, D). Thus, genes with kB
elements were generally upregulated in the PFC in alcoholics;
these genes may be derepressed due to decreased activity of the
p50 homodimer, an inhibitor of transcription and a dominant kB
binding factor.
DISCUSSION
The main findings of the present study are that DNA-binding
of NF-kB and p50 homodimer as well as RELA gene expression
are downregulated in the PFC of chronic alcoholics. The
downregulation of DNA-binding might result from the decrease
in RELA gene expression, and from the alterations in stoichiometry
in p65, p50 and IKKb proteins (Figure 6). p65 and p50 proteins
constitute NF-kB and p50 homodimer while IKKb integrates
signals regulating the NF-kB system through phosphorylation of
IkBa and p65. No significant differences between control and
alcoholic groups in the NF-kB system were found in the MC
suggesting that dysregulation of NF-kB-mediated adaptive mech-
anisms is specific for the PFC.
Several factors may affect the quality of RNA and proteins, and
DNA binding activities of transcription factors in postmortem
human tissues. In the present study, the RNA quality was
controlled and no samples with degraded RNA were used in the
analysis. No degraded proteins seen as smearing or additional
bands on western blots were evident in any sample. Using our
protocol for fast extraction of nuclear proteins from frozen tissues,
we observed similar levels of the NF-kB/p50 homodimer DNA
binding activities in extracts of frozen human samples and of rat
brain tissues prepared immediately after decapitation, thus
demonstrating low if any inactivation of these factors in human
samples. Six subjects demonstrated no NF-kB, p50 homodimer
and Ku protein DNA binding activity were characterized by low
brain pH values and were omitted from the analysis. Levels of
RNA, proteins and NF-kB/p50 homodimer DNA-binding did not
significantly correlate with postmortem interval and age at death
of subjects analyzed suggesting that influences of these covariates
on studied molecular parameters are negligible.
NF-kB is classically activated through dissociation from IkBi n
the cytoplasm [15–17,20–22,51]. DNA-binding and transactiva-
tion functions are also regulated through posttranslational
Figure 5. kB elements in genes differentially expressed in alcoholics.
Frequencies of occurrence of the ‘‘NF-kB’’- and ‘‘p50 homodimer’’-
subtypes of kB binding sites in 270 and 209 genes downregulated and
upregulated in alcoholics, respectively, and 1164 control genes (Table
S1). (A,B) Matrices from the JASPAR database (http://mordor.cgb.ki.se/
cgi-bin/jaspar2005/jaspar_db.pl) used to identify ‘‘NF-kB’’ (A) and ‘‘p50
homodimer’’ (B) subtypes of kB binding sites. Both NF-kB and p50
homodimer bind to the ‘‘NF-kB’’ subtype of kB elements with high
affinity and specificity whereas p50 homodimer has higher affinity for
more symmetric ‘‘p50 homodimer’’-subtype of kB binding sites [51,52].
The matrix logos provide visual representation profiles of nucleotide
conservation in kB elements. The maximal conservation amounts are 2
bits for each position. Higher conservation indicates increased bi-
ological importance for a base. (C, D). Frequencies of occurrence of the
‘‘NF-kB’’- (C) and ‘‘p50 homodimer’’- (D) subtypes of kB binding sites in
270 and 209 genes downregulated and upregulated in alcoholics,
respectively, and in 1164 control genes (Table S1). Significance of
differences between upregulated, downregulated and control genes in
the frequency of occurrence of genes with kB elements were evaluated
with Chi-square test (df=2). Pairwise comparison of the up- with
downregulated genes, the upregulated with control genes, and the
downregulated with control genes was performed with Chi Square test
(df=1). ** P,0.01, * P,0.05.
doi:10.1371/journal.pone.0000930.g005
Figure 6. Model for the molecular adaptations in the NF-kB system in
the PFC in alcoholics. (A) Chronic alcohol intake inhibits RELA gene
transcription and induces alterations in stoichiometry of RELA/NFKB1
mRNAs and p65/p50 proteins, resulting in downregulation of NF-kB
DNA-binding. In cells with dominant NF-kB this adaptation results
in inhibition of NF-kB-dependent transcription. (B) Alcohol acts
upstream of an unidentified protein kinase that modulates DNA-
binding of the p50 homodimer. This results in hypophosphorylation of
p50 and downregulation of p50 homodimer DNA-binding. In control
individuals the p50 homodimer inhibits gene transcription acting
through kB binding sites in cells in which it prevails over NF-kB.
In alcoholics, downregulation of the p50 homodimer eliminates
transcriptional repression leading to upregulation of kB-mediated
transcription. Dysregulation of the NF-kB/p50 homodimer-dependent
gene transcription contributes to cellular neuroplastic adaptations and
neurodegeneration.
doi:10.1371/journal.pone.0000930.g006
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lation at several sites by the IKK complex increases the DNA
binding and transcriptional activities of p65 [20,51,55]. p50
phosphorylation by protein kinase A and other kinases is critical
for binding of the p50 homodimer to DNA, which results in
transcriptional repression of NF-kB dependent genes [18,19]. In
the apparent absence of changes in the p50 content, the
downregulation of p50 homodimer DNA-binding in chronic
alcoholics may occur due to the deficient phosphorylation of this
protein (Figure 6).
The p50 homodimer is capable of suppressing the transactiva-
tion activities of NF-kB by occupying the same kB sites and
recruiting corepressor complexes containing histone deacetylases
(HDAC) [56]. We found that the p50 homodimer is the dominant
kB binding factor in the human PFC. Bioinformatic analysis
demonstrated that the proportion of genes with putative kB
elements was significantly higher in the set of genes upregulated in
the PFC of alcoholics compared to the set of downregulated genes.
The most plausible explanation for these observations is that in
alcoholics the p50 homodimer-induced repression of gene
transcriptions weakens due to the p50 homodimer downregulation
thus allowing the recruitment of NF-kB that activates transcription
from kB elements.
Genes differentially expressed in the PFC in alcoholics were
previously pooled into 16 groups according to their functions
associated with apoptosis, immune/stress response, myelination
and gene transcription [14]. Genes in 14 out of 16 groups have
putative NF-kB binding sites (Table S5). Among the upregulated
genes in alcoholics is the death–associated protein 6 (DAXX). It is
involved in cell survival/cell death and spatial learning processes.
Interestingly, DAXX acts as an anti-apoptotic regulator [57]
through its ability to repress gene transcription activated by NF-kB
and other transcription factors [58]. Overall, bioinformatic data
support the notion of a critical role of adaptations in the NF-kB/
p50 system in the differential regulation of gene expression in the
PFC of chronic alcoholics.
Tight spatio-temporal co-expression of genes functioning in the
same cell-biological process is a widespread phenomenon in
eukaryotes [59,60]. Synexpression groups have been found to be
coordinated by trans-acting factors regulating common promoter
elements [59,60]. Strong correlation between content of RELA,
NFKB1, IKKb and IkBa mRNAs suggests common regulation of
transcription for these four genes. This mechanism appears to
operate in the PFC but not in the MC where no strong
correlations between these four mRNAs were observed.
Several animal studies suggest that chronic alcohol intake alters
CNS immune and inflammatory responses through interference
with NF-kB and expression of NF-kB-controlled genes [61–64].
Thus, chronic alcohol administration up-regulates inflammatory
mediators in the animal brain and isolated astrocytes followed by
activation of NF-kB and the upregulation of inducible NO
synthase and cyclooxygenase-2 expression [61,62]. Neuroinflam-
mation may be also promoted by serum TNFa and other cytokines
elevated due to systemic and hepatic inflammation induced by
alcohol drinking [63]. Serum cytokines apparently enter the brain
where they activate microglia. Serum and brain-produced TNFa
acting through the NF-kB system may inhibit glutamate transport
and, consequently, induce a hyperglutamatergic state that
contributes to increased drinking and neurodegeneration [63].
Withdrawal from alcohol results in neuronal excitation
[1,65,66] through activation of glutamate receptors and calcium
influx; both stimuli activate NF-kB [15,16,25–27]. Cycles of
alcohol intoxication and withdrawal, which initially activate NF-
kB, when repeated over years may lead to adaptations in NF-kB
that tolerate excessive stimulation. This hypothesis is supported by
animal studies demonstrating that acute ethanol administration
activates the NF-kB system in the brain [67,68], which is then
downregulated when ethanol is administered for the next three
weeks [67]. Another adaptation to chronic alcohol consumption is
the downregulation of the p50 homodimer, a dominant kB-
binding factor in human cortex. This apparently results in
derepression of genes regulated through kB-elements in their
promoters. These types of adaptations, ensuring a low responsive-
ness and/or compensatory response to chronic stimulation, differ
from that observed in the immune system [69,70], which is based
on the over-expression of the inhibitory p50 subunit.
Several lines of evidence demonstrate that NF-kB plays an
important role in synaptic plasticity and long-term memory
[15,16,25–29]. This factor is regulated by glutamate and required
for LTP/LTD [28], fear conditioning [71] and spatial memory
[26,72]. NF-kB regulates, through its effects on expression of
PKA, phosphorylation of CREB that is essential for transduction
of synaptic signals into the cell nucleus and eventually for learning
and memory [29]. These studies imply that adaptations in NF-kB
in chronic alcoholics may influence neurocognitive functions
through dysregulation of expression of PKA and other plastic genes
in neurons.
In animal studies, upregulation of DFosB, a product of the Fosb
gene induced by chronic administration of virtually all drugs of
abuse was found to persists for several weeks and may maintain
stable expression of genes associated with drug addiction [73,74].
Dysregulation of the NF-kB system observed in the present study is
associated with chronic alcoholism, and as such represents the first
example of sustained transcriptional adaptation to chronic intake
of substances of abuse in the human brain. The sustained
adaptations in the NF-kB system apparently represent a shift to
new steady state or allostatic levels in the NF-kB/p50 activities
that may underlie persistent alterations in expression of their target
genes. Multiple mechanisms may ensure the stability of alterations
that, hypothetically, may involve a) the feedback loop between NF-
kB and IkB [75]; b) feed-back and feed-forward NF-kB/p50
interactions with other transcription factors such as DAXX [58],
glucocorticoid receptors [76], SP-1 [77] and CREB [29].
In conclusion, we have found that chronic alcohol consumption
downregulates NF-kB and p50 homodimer in the PFC of human
brain. These adaptations may be induced through several
mechanisms that a) regulate transcription of the RELA gene, b)
maintain the stoichiometry of p65 and p50 proteins, and c) control
DNA-binding of p50 homodimer possibly via its phosphorylation
(Figure 6). NF-kB may be targeted through the glutamate
receptors, calcium influx and oxidative processes [15,16,25–28],
all affected by cycles of alcohol consumption and withdrawal.
Allostasis in the NF-kB system found in the present study may
ensure tolerance and/or compensatory response to excessive
stimulation in chronic alcoholics. Downregulation of the inhibitory
p50 homodimer apparently contributes to the enhanced expres-
sion of genes regulated through kB elements in the PFC in
alcoholics. Adaptations in the NF-kB system may be essential for
persistent neuroplastic changes and neurodegeneration underlying
dependence to alcohol and associated impairment of cognitive
functions. An important role of the NF-kB system in alcoholism is
emphasized by the recent animal transcriptome meta-analysis [78]
and the human genetics findings. The NF-kB signaling pathway
was found to be overrepresented in genes divergent between
alcohol-preferring and nonpreferring mouse genotypes suggesting
the participation of this system in establishing a high level of
voluntary alcohol drinking [78]. The Collaborative Study on the
Genetics of Alcoholism reported evidence for association of
NF-kB system in alcoholics
PLoS ONE | www.plosone.org 9 September 2007 | Issue 9 | e930variations in the NFKB1 (p50) gene with the risk for alcoholism
(data presented at the International Narcotic Research Confer-
ence, 2005; with permission of Dr. Howard Edenberg).
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